Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Patient Cohort

KA Kristine Aasebø
AD Anca Dragomir
MS Magnus Sundström
AM Artur Mezheyeuski
PE Per-Henrik Edqvist
GE Geir Egil Eide
FP Fredrik Ponten
PP Per Pfeiffer
BG Bengt Glimelius
HS Halfdan Sorbye
request Request a Protocol
ask Ask a question
Favorite

A prospectively collected cohort was established of all non-resectable mCRC patients referred to the oncology units of three regional hospitals in Scandinavia: Odense University Hospital (Denmark) (n = 325), Uppsala University Hospital (Sweden) (n = 155), and Haukeland University Hospital (Norway) (n = 316) during 2003–2006 with last follow-up in 2014. These hospitals cover all oncology treatment in their region. Cases not referred in the region were identified through the national (Norway and Sweden) and regional (Denmark) cancer registries (n = 49). The cohort consists of 796 patients (Figure 1).

Flow chart describing collection of tumor blocks, tissue microarray (TMA), and availability of CDX2 status in a population-based Scandinavian cohort of metastatic colorectal cancer.

Copyright and License information:  ©2020 Aasebø, Dragomir, Sundström, Mezheyeuski, Edqvist, Eide, Ponten, Pfeiffer, Glimelius and Sorbye.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A